Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves.

Here's a compilation of five stocks that should be on your radar in the week of June 13:

1. Novavax

Novavax, Inc. (NASDAQ:NVAX) stock retreated last week after there was no word on the authorization of its COVID-19 vaccine in the U.S. An advisory committee of the Food and Drug Administration that met last Tuesday unanimously recommended the approval of the vaccine. The FDA has yet to give the final verdict.

Rival vaccines...